Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
115.24
+3.06 (2.73%)
Mar 5, 2026, 4:00 PM EST - Market closed
Celcuity Employees
Celcuity had 87 employees as of December 31, 2024. The number of employees increased by 32 or 58.18% compared to the previous year.
Employees
87
Change (1Y)
32
Growth (1Y)
58.18%
Revenue / Employee
n/a
Profits / Employee
-$1,870,369
Market Cap
5.33B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,769 |
| PTC Therapeutics | 991 |
| CRISPR Therapeutics AG | 393 |
| Mirum Pharmaceuticals | 372 |
| Immunovant | 362 |
| Cogent Biosciences | 258 |
| Apogee Therapeutics | 196 |
| CG Oncology | 142 |
CELC News
- 3 days ago - Artisan International Small-Mid Fund Q4 2025 Performance Review - Seeking Alpha
- 8 days ago - Celcuity To Participate in Upcoming Investor Conferences - GlobeNewsWire
- 20 days ago - Celcuity Inc. (CELC) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 21 days ago - Celcuity Appoints Charles Romp to its Board of Directors - GlobeNewsWire
- 4 weeks ago - Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 6 weeks ago - These 20 stocks are strong choices for momentum investors - Market Watch
- 6 weeks ago - Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer - GlobeNewsWire
- 2 months ago - Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond - Seeking Alpha